Allan J Kozlowski1, David Cella2, Kristian P Nitsch3, Allen W Heinemann4. 1. Department of Rehabilitation Medicine, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: allan.kozlowski@mssm.edu. 2. Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL. 3. Center for Rehabilitation Outcomes Research, Rehabilitation Institute of Chicago, Chicago, IL; Department of Psychology, Illinois Institute of Technology, Chicago, IL. 4. Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL; Center for Rehabilitation Outcomes Research, Rehabilitation Institute of Chicago, Chicago, IL; Department of Physical Medicine and Rehabilitation, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Abstract
OBJECTIVE: To provide a clinically useful means of interpreting change for individual patients on the Quality of Life in Neurological Disorders (Neuro-QoL) adult short forms (SFs) by applying a classical test theory concept for interpreting individual change. DESIGN: Secondary analysis of existing data. SETTING: Community. PARTICIPANTS: Persons with neurologic conditions including stroke, epilepsy, amyotrophic lateral sclerosis, multiple sclerosis, and Parkinson disease residing in community settings. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Neuro-QoL SFs for Applied Cognition-General Concerns, Applied Cognition-Executive Function, Applied Cognition-Combined, Ability to Participate in Social Roles and Activities, Satisfaction With Social Roles and Activities, Positive Affect and Well-Being, Depression, Stigma, Upper Extremity Function (Fine Motor, Activities of Daily Living), Lower Extremity Function (Mobility), Anxiety, Sleep Disturbance, Fatigue, and Emotional and Behavioral Dyscontrol. We estimated conditional minimal detectable change (cMDC) indices from the pooled SEs adjusted for a 95% confidence interval using the average of the SEs for any given pair of scores multiplied by the z score, or ([SE(Score1) + SE(Score2)]/2) * (1.96) * (SQRT(2)). RESULTS: The cMDC indices are generally smallest in the midrange of all scales, ranging from 3.6 to 11.2 T-score points, and higher on the outer quartiles ranging from 3.7 to 21.6 T-score points. The lowest midrange cMDCs were for Satisfaction With Social Roles and Activities (3.6-4.7 T-score points), and the largest were for Sleep Disturbance (9.4-11.2 T-score points). CONCLUSIONS: Change indices can help clinicians and investigators identify differences for individual patients or subjects that are large enough to motivate treatment change. cMDCs can reduce misclassification of magnitudes of change that are near the margins of error across the range of the Neuro-QoL SFs.
OBJECTIVE: To provide a clinically useful means of interpreting change for individual patients on the Quality of Life in Neurological Disorders (Neuro-QoL) adult short forms (SFs) by applying a classical test theory concept for interpreting individual change. DESIGN: Secondary analysis of existing data. SETTING: Community. PARTICIPANTS: Persons with neurologic conditions including stroke, epilepsy, amyotrophic lateral sclerosis, multiple sclerosis, and Parkinson disease residing in community settings. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Neuro-QoL SFs for Applied Cognition-General Concerns, Applied Cognition-Executive Function, Applied Cognition-Combined, Ability to Participate in Social Roles and Activities, Satisfaction With Social Roles and Activities, Positive Affect and Well-Being, Depression, Stigma, Upper Extremity Function (Fine Motor, Activities of Daily Living), Lower Extremity Function (Mobility), Anxiety, Sleep Disturbance, Fatigue, and Emotional and Behavioral Dyscontrol. We estimated conditional minimal detectable change (cMDC) indices from the pooled SEs adjusted for a 95% confidence interval using the average of the SEs for any given pair of scores multiplied by the z score, or ([SE(Score1) + SE(Score2)]/2) * (1.96) * (SQRT(2)). RESULTS: The cMDC indices are generally smallest in the midrange of all scales, ranging from 3.6 to 11.2 T-score points, and higher on the outer quartiles ranging from 3.7 to 21.6 T-score points. The lowest midrange cMDCs were for Satisfaction With Social Roles and Activities (3.6-4.7 T-score points), and the largest were for Sleep Disturbance (9.4-11.2 T-score points). CONCLUSIONS: Change indices can help clinicians and investigators identify differences for individual patients or subjects that are large enough to motivate treatment change. cMDCs can reduce misclassification of magnitudes of change that are near the margins of error across the range of the Neuro-QoL SFs.
Authors: Robroy L Martin; James J Irrgang; Ray G Burdett; Stephen F Conti; Jessie M Van Swearingen Journal: Foot Ankle Int Date: 2005-11 Impact factor: 2.827
Authors: D Cella; J-S Lai; C J Nowinski; D Victorson; A Peterman; D Miller; F Bethoux; A Heinemann; S Rubin; J E Cavazos; A T Reder; R Sufit; T Simuni; G L Holmes; A Siderowf; V Wojna; R Bode; N McKinney; T Podrabsky; K Wortman; S Choi; R Gershon; N Rothrock; C Moy Journal: Neurology Date: 2012-05-09 Impact factor: 9.910
Authors: Surbhi Sidana; Cristine Allmer; Melissa C Larson; Amylou Dueck; Kathleen Yost; Rahma Warsame; Gita Thanarajasingam; James R Cerhan; Jonas Paludo; S Vincent Rajkumar; Thomas M Habermann; Grzegorz S Nowakowski; Yi Lin; Morie A Gertz; Thomas Witzig; Angela Dispenzieri; Wilson I Gonsalves; Stephen M Ansell; Carrie A Thompson; Shaji K Kumar Journal: JCO Oncol Pract Date: 2022-05-17
Authors: Surbhi Sidana; Amylou C Dueck; Gita Thanarajasingam; Joan M Griffin; Carrie Thompson; Urshila Durani; Michelle Burtis; Rahma Warsame; Jonas Paludo; Morie A Gertz; Angela Dispenzieri; Stephen M Ansell; S Vincent Rajkumar; Kathleen Yost; Nora Bennani; Yi Lin; Shaji Kumar Journal: Transplant Cell Ther Date: 2022-05-09
Authors: A S Adams; J A Schmittdiel; A Altschuler; E A Bayliss; R Neugebauer; L Ma; W Dyer; J Clark; B Cook; D Willyoung; M Jaffe; J D Young; E Kim; J M Boggs; L A Prosser; E Wittenberg; B Callaghan; M Shainline; R M Hippler; R W Grant Journal: Diabet Med Date: 2018-11-07 Impact factor: 4.359
Authors: Noelle E Carlozzi; Nicholas R Boileau; Jane S Paulsen; Nancy R Downing; Rebecca Ready; Joel S Perlmutter; David Cella; Kelvin L Chou; Michael K McCormack; Stacey Barton; Jin-Shei Lai Journal: Qual Life Res Date: 2019-12-18 Impact factor: 4.147
Authors: Connie Marras; Kelly A Mills; Shirley Eberly; David Oakes; Kelvin L Chou; Matthew Halverson; Sotirios A Parashos; Christopher G Tarolli; Jin-Shei Lai; Cindy J Nowinsky; Oksana Suchowersky; Eric S Farbman; Lisa M Shulman; Tanya Simuni Journal: Mov Disord Date: 2021-05-13 Impact factor: 9.698